Up a level |
2023
Arndt, Volker ORCID: 0000-0001-9320-8684, Doege, Daniela, Froehling, Stefan, Albers, Peter ORCID: 0000-0002-1747-9615, Alguel, Hana, Bargou, Ralf, Bokemeyer, Carsten, Bornhaeuser, Martin, Brandts, Christian H. ORCID: 0000-0003-1732-2535, Brossart, Peter, Brucker, Sara Yvonne, Bruemmendorf, Tim H., Doehner, Hartmut, Gattermann, Norbert, Hallek, Michael, Heinemann, Volker, Keilholz, Ulrich, Kindler, Thomas, von Levetzow, Cornelia, Lordick, Florian, Neumann, Ulf Peter, Peters, Christoph, Schadendorf, Dirk, Stilgenbauer, Stephan, Zander, Thomas, Zips, Daniel ORCID: 0000-0001-5779-9675, Braun, Delia, Seufferlein, Thomas, Nettekoven, Gerd and Baumann, Michael ORCID: 0000-0002-9340-974X (2023). Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. J. Cancer Res. Clin. Oncol., 149 (2). S. 913 - 920. NEW YORK: SPRINGER. ISSN 1432-1335
2022
Lawless, Sarah, Morris, Curly, Eikema, Dirk-Jan, Kostner, Linda, Stoelzel, Friedrich, Kroeger, Nicolaus, Platzbecker, Uwe, Bethge, Wolfgang, Brossart, Peter, Fanin, Renato, Finke, Juergen, Kuball, Jurgen ORCID: 0000-0002-3914-7806, Leblond, Veronique, Nicholson, Emma, Passweg, Jakob, Avenoso, Daniele ORCID: 0000-0003-4218-4170, Bay, Jacques-Olivier, Bazarbachi, Ali, Caballero, Dolores, Drozd-Sokolowska, Joanna, Scheid, Christof, McLornan, Donal P., Robin, Marie and Yakoub-Agha, Ibrahim (2022). Outcomes of Allogeneic Haematopoietic Stem Cell Transplantation for Therapy-Related Myeloid Neoplasms Following Treatment for Myeloma. Blood, 140. S. 4884 - 4886. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Schmitz, Friederike, Neuerburg, Charlotte, Schumacher, Martin, Holtick, Udo, Jost, Edgar, Kobbe, Guido, Barmann, Ben-Niklas, Schmitz, Marie-Therese, Schmid, Matthias, Brossart, Peter, Holderried, Martin and Holderried, Tobias A. W. (2022). The Potential of E-Health in Patients after Allogeneic Stem Cell Transplantation. Blood, 140. S. 7966 - 7968. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
2021
Baertsch, Marc-Andrea, Mai, Elias K., Hielscher, Thomas, Bertsch, Uta, Salwender, Hans J., Munder, Markus, Fuhrmann, Stephan ORCID: 0000-0002-7785-2565, Duehrsen, Ulrich, Brossart, Peter, Neben, Kai, Schlenzka, Jana, Kunz, Christina, Raab, Marc S., Hillengass, Jens, Jauch, Anna, Seckinger, Anja, Hose, Dirk, Luntz, Steffen, Sonneveld, Pieter, Lokhorst, Henk, Martin, Hans, Goerner, Martin, Hoffmann, Martin, Lindemann, Hans-Walter, Bernhard, Helga, Blau, Igor W., Scheid, Christof, Besemer, Britta, Weisel, Katja C., Haenel, Mathias, Duerig, Jan and Goldschmidt, Hartmut (2021). Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma. Blood Cancer J., 11 (1). LONDON: SPRINGERNATURE. ISSN 2044-5385
Goeser, Felix ORCID: 0000-0003-3190-9981, Sifft, Barbara, Stein-Thoeringer, Christoph, Farowski, Fedja, Strassburg, Christian P., Brossart, Peter, Higgins, Paul G. ORCID: 0000-0001-8677-9454, Scheid, Christoph, Wolf, Dominik, Holderried, Tobias A. W., Vehreschild, Maria J. G. T. and Cruz Aguilar, Marta Rebeca (2021). Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers. Eur. J. Haematol., 107 (2). S. 229 - 246. HOBOKEN: WILEY. ISSN 1600-0609
Juette, Bianca B., Krollmann, Calvin, Cieslak, Kevin, Koerber, Ruth-Miriam, Boor, Peter, Graef, Claus M., Bartok, Eva ORCID: 0000-0003-0556-1950, Wagner, Mirko, Carell, Thomas, Landsberg, Jennifer, Aymans, Pia, Wenzel, Jorg, Brossart, Peter and Teichmann, Lino L. (2021). Intercellular cGAMP transmission induces innate immune activation and tissue inflammation in Trex1 deficiency. iScience, 24 (8). CAMBRIDGE: CELL PRESS. ISSN 2589-0042
Klein, Eva-Maria, Tichy, Diana, Salwender, Hans J., Mai, Elias K., Duerig, Jan, Weisel, Katja C., Benner, Axel, Bertsch, Uta, Akhavanpoor, Mabast, Besemer, Britta, Munder, Markus, Lindemann, Hans-Walter, Hose, Dirk, Seckinger, Anja, Luntz, Steffen, Jauch, Anna, Elmaagacli, Ahmet, Fuhrmann, Stephan, Brossart, Peter, Goerner, Martin, Bernhard, Helga, Raab, Marc S., Blau, Igor W., Haenel, Mathias, Scheid, Christof and Goldschmidt, Hartmut (2021). Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial. Cancers, 13 (19). BASEL: MDPI. ISSN 2072-6694
Salwender, Hans, Elmaagacli, Ahmet, Merz, Maximilian, Miah, Kaya, Benner, Axel, Haenel, Mathias, Jehn, Christian, Mai, Elias K., Bertsch, Uta, Blau, Igor W., Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Raab, Marc S., Luntz, Steffen P., Besemer, Britta, Munder, Markus, Brossart, Peter, Fuhrmann, Stephan, Lindemann, Hans-Walter, Weisel, Katja, Duerig, Jan and Goldschmidt, Hartmut (2021). Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial. Leukemia, 35 (10). S. 3007 - 3012. LONDON: SPRINGERNATURE. ISSN 1476-5551
2020
Goldschmidt, Hartmut, Mai, Elias K., Duerig, Jan, Scheid, Christof, Weisel, Katja C., Kunz, Christina, Bertsch, Uta, Hielscher, Thomas, Merz, Maximilian, Munder, Markus, Lindemann, Hans-Walter, Huegle-Doerr, Barbara, Tichy, Diana, Giesen, Nicola, Hose, Dirk, Seckinger, Anja, Huhn, Stefanie, Luntz, Steffen, Jauch, Anna, Elmaagacli, Ahmet, Rabold, Bernhard, Fuhrmann, Stephan, Brossart, Peter, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Hillengass, Jens, Raab, Marc S., Blau, Igor W., Haenel, Mathias and Salwender, Hans J. (2020). Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial. Leukemia, 34 (7). S. 1853 - 1866. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
2019
Mai, Elias K., Hielscher, Thomas, Bertsch, Uta, Schlenzka, Jana, Salwender, Hans J., Munder, Markus, Gerecke, Christian, Duehrsen, Ulrich, Brossart, Peter, Neben, Kai, Hillengass, Jens, Raab, Marc S., Merz, Maximilian, Baertsch, Marc-Andrea, Jauch, Anna, Hose, Dirk, Martin, Hans, Lindemann, Hans-Walter, Blau, Igor W., Scheid, Christof, Weisel, Katja C. and Goldschmidt, Hartmut (2019). Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma. Leukemia, 33 (1). S. 258 - 262. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Michel, Christian, Burchert, Andreas, Hochhaus, Andreas, Saussele, Susanne, Neubauer, Andreas, Lauseker, Michael, Krause, Stefan W., Kolb, Hans-Jochem, Hossfeld, Dieter Kurt, Nerl, Christoph, Baerlocher, Gabriela M., Heim, Dominik, Bruemmendorf, Tim H., Fabarius, Alice, Haferlach, Claudia, Schlegelberger, Brigitte, Balleisen, Leopold, Goebeler, Maria-Elisabeth, Haenel, Mathias, Ho, Anthony, Dengler, Jolanta, Falge, Christiane, Moehle, Robert, Kremers, Stephan, Kneba, Michael, Stegelmann, Frank, Koehne, Claus-Henning, Lindemann, Hans-Walter, Waller, Cornelius F., Spiekermann, Karsten, Berdel, Wolfgang E., Mueller, Lothar, Edinger, Matthias, Mayer, Jiri, Beelen, Dietrich W., Bentz, Martin, Link, Hartmut, Hertenstein, Bernd, Fuchs, Roland, Wernli, Martin, Schlegel, Frank, Schlag, Rudolf, de Wit, Maike, Truemper, Lorenz, Hebart, Holger, Hahn, Markus, Thomalla, Joerg, Scheid, Christof, Schafhausen, Philippe, Verbeek, Walter, Eckart, Michael J., Gassmann, Winfried, Schenk, Michael, Brossart, Peter, Wuendisch, Thomas, Geer, Thomas, Bildat, Stephan, Schaefer, Erhardt, Hasford, Joerg, Hehlmann, Ruediger and Pfirrmann, Markus (2019). Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV. Haematologica, 104 (5). S. 955 - 963. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
2018
Baertsch, Marc-A., Schlenzka, Jana, Christina, Habermehl, Hielscher, Thomas, Raab, Marc S., Hillengass, Jens, Mueller-Tidow, Carsten, Luntz, Steffen, Jauch, Anna, Brossart, Peter, Goerner, Martin, Klein, Stefan A., Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Haenel, Mathias, Martin, Hans, Lindemann, Hans-Walter, Scheid, Christoph, Nogai, Axel, Salwender, Hans Juergen, Noppeney, Richard, Weisel, Katja and Goldschmidt, Hartmut (2018). Subgroup Analyses of the Randomized GMMG Phase III Multicenter Trial Relapse Suggest Survival Benefit of Salvage Autologous Transplant Primarily in Low Risk Multiple Myeloma. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Goldschmidt, Hartmut, Baertsch, Marc-A., Schlenzka, Jana, Becker, Natalia, Christina, Habermehl, Hielscher, Thomas, Raab, Marc S., Hillengass, Jens, Mueller-Tidow, Carsten, Luntz, Steffen, Jauch, Anna, Brossart, Peter, Goerner, Martin, Klein, Stefan A., Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Haenel, Mathias, Martin, Hans, Lindemann, Hans-Walter, Scheid, Christoph, Nogai, Axel, Salwender, Hans Juergen, Noppeney, Richard and Weisel, Katja (2018). Salvage Autologous Transplant and Lenalidomide Maintenance Versus Continuous Lenalidomide/Dexamethasone for Relapsed Multiple Myeloma: Results of the Randomized GMMG Phase III Multicenter Trial Relapse. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
2016
Mai, Elias K., Benner, Axel, Bertsch, Uta, Brossart, Peter, Haenel, Annette, Kunzmann, Volker, Naumann, Ralph, Neben, Kai, Egerer, Gerlinde, Ho, Anthony D., Hillengass, Jens, Raab, Marc S., Neubauer, Andreas, Peyn, Astrid, Ko, Yon-Dschun, Peter, Norma, Scheid, Christof and Goldschmidt, Hartmut (2016). Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial. Br. J. Haematol., 173 (5). S. 731 - 742. HOBOKEN: WILEY. ISSN 1365-2141
Merz, Maximilian, Salwender, Hans ORCID: 0000-0001-7803-0814, Haenel, Mathias, Mai, Elias K., Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W., Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S., Schurich, Baerbel, Munder, Markus, Brossart, Peter, Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan and Goldschmidt, Hartmut (2016). Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial. Haematologica, 101 (12). S. E485 - 3. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
2015
Dietz, Christian T., Fabarius, Alice Charlotte, Lauseker, Michael, Saussele, Susanne, Kalmanti, Lida, Rinaldetti, Sebastien, Haferlach, Claudia, Schlegelberger, Brigitte, Jotterand, Martine, Gratwohl, Alois, Zander, Axel R., Kroeger, Nicolaus, Beelen, Dietrich W., Novotny, Juergen, Nerl, Christoph, Scheid, Christof, Spiekermann, Karsten, Mayer, Jiri, Sayer, Herbert G., Falge, Christiane, Bunjes, Donald, Doehner, Hartmut, Ganser, Arnold, Brossart, Peter, Schwerdtfeger, Rainer, Baumann, Herrad, Kuse, Rolf, Lindemann, Hans Walter, Bormann, Matthias, Hertenstein, Bernd, Baerlocher, Gabriela M., Aul, Carlo, Staib, Peter, Edinger, Matthias, Schatz, Michael, Fauser, Axel A., Arnold, Renate, Hossfeld, Dieter K., Kolb, Hans-Jochem, Schnittger, Susanne, Mueller, Martin C., Reiter, Andreas, Hochhaus, Andreas, Pfirrmann, Markus, Hasford, Joerg, Baccarani, Michele and Hehlmann, Ruediger (2015). Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Mai, Elias Karl ORCID: 0000-0002-6226-1252, Kunz, Christina, Bertsch, Uta, Salwender, Hans-Juergen, Pfreundschuh, Michael, Duehrsen, Ulrich, Brossart, Peter, Peter, Norma, Neben, Kai, Hielscher, Thomas, Hillengass, Jens, Martin, Hans, Lindemann, Hans Walter, Scheid, Christof, Weisel, Katja C., Blau, Igor W. and Goldschmidt, Hartmut (2015). Impact of Severe Infections during Induction Therapy on Dosage, Response and Survival in Newly Diagnosed Multiple Myeloma - a Subgroup Analysis from the Randomized Phase III Trial GMMG-HD4. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Merz, Maximillan, Salwender, Hans-Juergen, Haenel, Mathias, Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W., Scheid, Christof, Mai, Elias Karl ORCID: 0000-0002-6226-1252, Hose, Dirk, Schurich, Baerbel, Munder, Markus, Brossart, Peter, Gerecke, Christian, Lindemann, Hans Walter, Zeis, Matthias, Weisel, Katja C., Duerig, Jan and Goldschmidt, Hartmut (2015). Clinical Risk Factors for Peripheral Neuropathy in Patients Treated with Subcutaneous or Intravenous Bortezomib for Newly Diagnosed Multiple Myeloma. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Sonneveld, Pieter, Salwender, Hans-Juergen, Van der Holt, Bronno, el Jarari, Laila, Bertsch, Uta, Blau, Igor W., Zweegman, Sonja, Weisel, Katja C., Vellenga, Edo, Pfreundschuh, Michael, Broijl, Annemiek, Scheid, Christof, Wittebol, Shulamiet, Bos, Gerard M. J., Stevens-Kroef, Marjan, Jauch, Anna, Potamianou, Anna, Hose, Dirk, Raymakers, Reinier, Schaafsme, Marinus, Kersten, Marie Jose, Kooy, Marinus van Marwijk, Duehrsen, Ulrich, Lindemann, Hans Walter, Brossart, Peter, Wijermans, Pierre, Lokhorst, Henk M. and Goldschmidt, Hartmut (2015). Bortezomib Induction and Maintenance in Patients with Newly Diagnosed Multiple Myeloma: Long-Term Follow-up of the HOVON-65/GMMG-HD4 Trial. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
2014
Schuette, Ute, Bisht, Savita, Heukamp, Lukas C., Kebschull, Moritz ORCID: 0000-0003-1863-0679, Florin, Alexandra, Haarmann, Jens, Hoffmann, Per, Bendas, Gerd, Buettner, Reinhard, Brossart, Peter and Feldmann, Georg (2014). Hippo Signaling Mediates Proliferation, Invasiveness, and Metastatic Potential of Clear Cell Renal Cell Carcinoma. Transl. Oncol., 7 (2). S. 309 - 322. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1936-5233